Byline Bancorp Inc
F:44F
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Byline Bancorp Inc
F:44F
|
US |
|
Sequana Medical NV
XBRU:SEQUA
|
BE |
|
R
|
Ryanair Holdings PLC
XMUN:RY4C
|
IE |
|
Super Group Ltd
F:S8G1
|
ZA |
|
I
|
Impianti SpA
F:F67
|
IT |
|
E
|
eBay Inc
DUS:EBA
|
US |
|
S
|
Salesforce Inc
DUS:FOO
|
US |
|
E
|
Eight Capital Partners PLC
F:ECS
|
UK |
|
J
|
Jefferies Financial Group Inc
XBER:LN3
|
US |
|
Five Star Bancorp
F:4F6
|
US |
|
C
|
Chocoladefabriken Lindt & Spruengli AG
DUS:LSPP
|
CH |
|
T
|
Teck Resources Ltd
XMUN:TEKB
|
CA |
|
C
|
CNOOC Ltd
XMUN:NC2B
|
CN |
|
B
|
Basf Se
XMUN:BAS
|
DE |
|
B
|
Biogen Inc
XMUN:IDP
|
US |
|
M
|
Melco Resorts & Entertainment Ltd
F:MAS
|
HK |
Wall St Price Targets
44F Price Targets Summary
Byline Bancorp Inc
According to Wall Street analysts, the average 1-year price target for 44F is 25.5 EUR with a low forecast of 23.33 EUR and a high forecast of 28.53 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 44F's stock price target?
Price Target
25.5
EUR
According to Wall Street analysts, the average 1-year price target for 44F is 25.5 EUR with a low forecast of 23.33 EUR and a high forecast of 28.53 EUR.
What is the Revenue forecast for Byline Bancorp Inc?
Projected CAGR
5%
Over the last 10 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 2 years is 5%.
What is the Net Income forecast for Byline Bancorp Inc?
Projected CAGR
10%
The compound annual growth rate for Net Income over the next 2 years is 10%.
